FDA approves first vaccine for RSV, a moment six decades in the making
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Stay updated with breaking news from Steven Varga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Arexvy, made by GSK, is designed to be given as a single shot to adults 60 and older.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.